Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomization, Open-label Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients
Conditions
Interventions
Myreptic-N Tablet
Mycophenolate mofetil Tablet/Capsule
Locations
1
South Korea
Seoul National University Hospital
Seoul, South Korea
Start Date
November 14, 2023
Primary Completion Date
October 29, 2025
Completion Date
October 29, 2025
Last Updated
April 15, 2026
NCT05753930
NCT04128189
NCT05325008
NCT07412470
NCT05702398
NCT04870437
Lead Sponsor
Chong Kun Dang Pharmaceutical
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions